Cargando…

NAT10 as a potential prognostic biomarker and therapeutic target for HNSCC

BACKGROUND: Increasing evidence has demonstrated the critical roles of mRNA modification regulators on multiple types of cancers. However, it is still poorly known about the prognostic and therapeutic value of mRNA modification regulators in HNSCC. METHODS: The gene expression profile of 36 mRNA mod...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tao, Wenjie, Tian, Guocai, Xu, Shengming, Li, Jiayi, Zhang, Zhiyuan, Li, Jiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Primary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8344148/ https://www.ncbi.nlm.nih.gov/pubmed/34362389 http://dx.doi.org/10.1186/s12935-021-02124-2

Ejemplares similares

SYT7 acts as an oncogene and a potential therapeutic target and was regulated by ΔNp63α in HNSCC
por: Fu, You, et al.
Publicado: (2021)

Identification of four key prognostic genes and three potential drugs in human papillomavirus negative head and neck squamous cell carcinoma
por: Tian, Guocai, et al.
Publicado: (2021)

An HNSCC syngeneic mouse model for tumor immunology research and preclinical evaluation
por: Fu, You, et al.
Publicado: (2020)

Analysis of therapeutic targets and prognostic biomarkers of CXC chemokines in cervical cancer microenvironment
por: Kong, Weina, et al.
Publicado: (2021)

Identification of key genes for HNSCC from public databases using bioinformatics analysis
por: Ye, Yuchu, et al.
Publicado: (2021)

SNAP25 is a potential prognostic biomarker for prostate cancer
por: Di, Longjiang, et al.
Publicado: (2022)

YOD1 serves as a potential prognostic biomarker for pancreatic cancer
por: Zhang, Zhishuo, et al.
Publicado: (2022)

CLEC3B as a potential diagnostic and prognostic biomarker in lung cancer and association with the immune microenvironment
por: Sun, Jiaxing, et al.
Publicado: (2020)

Identification of a prognostic and therapeutic immune signature associated with hepatocellular carcinoma
por: Peng, Yanan, et al.
Publicado: (2021)

Secretory leukocyte protease inhibitor suppresses HPV E6-expressing HNSCC progression by mediating NF-κB and Akt pathways
por: Jin, Yu, et al.
Publicado: (2019)

NEIL3 may act as a potential prognostic biomarker for lung adenocarcinoma
por: Zhao, Cui, et al.
Publicado: (2021)

CPNE1 is a potential prognostic biomarker, associated with immune infiltrates and promotes progression of hepatocellular carcinoma
por: Su, Jinfang, et al.
Publicado: (2022)

A potential prognostic prediction model of colon adenocarcinoma with recurrence based on prognostic lncRNA signatures
por: Jin, Lipeng, et al.
Publicado: (2020)

Overexpression of kinesin superfamily members as prognostic biomarkers of breast cancer
por: Li, Tian-Fu, et al.
Publicado: (2020)

Construction and comprehensive analysis of a ceRNA network to reveal potential prognostic biomarkers for hepatocellular carcinoma
por: Long, Junyu, et al.
Publicado: (2019)

NR2F6 as a Prognostic Biomarker in HNSCC
por: Klapper, Luise, et al.
Publicado: (2020)

Identification of critical pathways and potential therapeutic targets in poorly differentiated duodenal papilla adenocarcinoma
por: Lu, Yuanxiang, et al.
Publicado: (2021)

H/ACA box small nucleolar RNA 7B acts as an oncogene and a potential prognostic biomarker in breast cancer
por: Sun, Yihan, et al.
Publicado: (2019)

Fewer tumour-specific PD-1(+)CD8(+) TILs in high-risk “Infiltrating” HPV(−) HNSCC
por: Xu, Ke, et al.
Publicado: (2020)

Identification of RPL5 and RPL10 as novel diagnostic biomarkers of Atypical teratoid/rhabdoid tumors
por: Ren, Yanming, et al.
Publicado: (2018)

Targeting Lymphotoxin Beta and Paired Box 5: a potential therapeutic strategy for soft tissue sarcoma metastasis
por: Huang, Runzhi, et al.
Publicado: (2021)

Evaluating the role of RAD52 and its interactors as novel potential molecular targets for hepatocellular carcinoma
por: Li, Ping, et al.
Publicado: (2019)

Targeted Proteomic Quantitation of NRF2 Signaling and Predictive Biomarkers in HNSCC
por: Wamsley, Nathan T., et al.
Publicado: (2023)

Expression profile analysis identifies key genes as prognostic markers for metastasis of osteosarcoma
por: Guan, Xiaoqing, et al.
Publicado: (2020)

Analysis of myosin genes in HNSCC and identify MYL1 as a specific poor prognostic biomarker, promotes tumor metastasis and correlates with tumor immune infiltration in HNSCC
por: Li, Ce, et al.
Publicado: (2023)

Evaluation of prognostic biomarkers in a population-validated Finnish HNSCC patient cohort
por: Routila, J., et al.
Publicado: (2021)

TRIM21 Expression as a Prognostic Biomarker for Progression-Free Survival in HNSCC
por: von Bernuth, Amelie, et al.
Publicado: (2023)

Correlation of CCL8 expression with immune cell infiltration of skin cutaneous melanoma: potential as a prognostic indicator and therapeutic pathway
por: Yang, Peipei, et al.
Publicado: (2021)

LRRK2 is a candidate prognostic biomarker for clear cell renal cell carcinoma
por: Yang, Chunxiu, et al.
Publicado: (2021)

Identification of potential biomarkers and candidate small molecule drugs in glioblastoma
por: Lu, Wei-cheng, et al.
Publicado: (2020)

Pre-treatment prognostic nutritional index may serve as a potential biomarker in urinary cancers: a systematic review and meta-analysis
por: Qi, Feng, et al.
Publicado: (2018)

Analyzing the lncRNA, miRNA, and mRNA-associated ceRNA networks to reveal potential prognostic biomarkers for glioblastoma multiforme
por: Zhu, Xiaolong, et al.
Publicado: (2020)

FOXD3 may be a new cellular target biomarker as a hypermethylation gene in human ovarian cancer
por: Luo, Gui-fang, et al.
Publicado: (2019)

VWCE as a potential biomarker associated with immune infiltrates in breast cancer
por: Huo, Qin, et al.
Publicado: (2021)

Exosomal circRNA as a novel potential therapeutic target for multiple myeloma-related myocardial damage
por: Sun, Runjie, et al.
Publicado: (2021)

Identification of NEO1 as a prognostic biomarker and its effects on the progression of colorectal cancer
por: Zhang, Meng, et al.
Publicado: (2020)

MiR-34a and miR-206 act as novel prognostic and therapy biomarkers in cervical cancer
por: Chen, Ai-Hua, et al.
Publicado: (2017)

ANLN and UBE2T are prognostic biomarkers associated with immune regulation in breast cancer: a bioinformatics analysis
por: Xiao, Yu, et al.
Publicado: (2022)

Potential new biomarkers for endometrial cancer
por: Townsend, Michelle H., et al.
Publicado: (2019)

The prognostic potential of coilin in association with p27 expression in pediatric acute lymphoblastic leukemia for disease relapse
por: Yue, Zhi-Xia, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_1vf002lsuqjdoe27mtuo37vb47